93. Primary biliary cholangitis Clinical trials / Disease details


Clinical trials : 282 Drugs : 245 - (DrugBank : 56) / Drug target genes : 35 - Drug target pathways : 113

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05133336
(ClinicalTrials.gov)
March 15, 20221/11/2021Saroglitazar Magnesium for Treatment of Primary Biliary CholangitisA Multicenter, Randomized, Double-blind, Placebo Controlled, Phase 2b/3 Study to Evaluate the Efficacy and Safety of Saroglitazar Magnesium in Subjects With Primary Biliary CholangitisPrimary Biliary CholangitisDrug: Saroglitazar Magnesium 1 mg;Drug: Saroglitazar Magnesium 2 mg;Drug: PlaceboZydus Therapeutics Inc.NULLNot yet recruiting18 Years75 YearsAll192Phase 2/Phase 3NULL